This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Constellation Pharmaceuticals, Inc., Genentech, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 56 
1 out of 3,300 
Years Active: 2018
Title: James Kiefer: Innovator in Histone Demethylase Inhibition
Introduction
James Kiefer is a notable inventor based in South San Francisco, California. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that serve as inhibitors of histone demethylases.
Latest Patents
Kiefer holds a patent for "Pyrrolidine amide compounds as histone demethylase inhibitors." This invention relates to compounds that are useful in inhibiting one or more histone demethylases, such as KDM5. The patent also includes pharmaceutically acceptable compositions comprising these compounds and methods for using them in the treatment of various disorders.
Career Highlights
Throughout his career, Kiefer has worked with prominent companies in the biotechnology sector, including Genentech, Inc. and Constellation Pharmaceuticals, Inc. His work has contributed to advancements in therapeutic strategies targeting epigenetic modifications.
Collaborations
Kiefer has collaborated with notable professionals in his field, including Kwong Wah Lai and Jun Liang. These collaborations have likely enhanced the research and development of his innovative compounds.
Conclusion
James Kiefer's work in developing histone demethylase inhibitors showcases his commitment to advancing medical science. His contributions are significant in the ongoing quest for effective treatments for various disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile